Yes! Paragon CRT® Contact Lenses are the first therapeutic lens design approved by the FDA for overnight orthokeratology for the temporary reduction of myopia. Paragon Vision Sciences, the manufacturer of Paragon CRT® Contact Lenses, received final FDA approval on June 13, 2002, which was the culmination of the most extensive clinical study of overnight orthokeratology to-date.